Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

Renxian Wang; WeiFeng Liu; Qian Wang; Guangping Li; Ben Wan; Yuyang Sun; Xiaohui Niu; Dafu Chen; Wei Tian

doi:10.1039/D1BM90066H

You do not have JavaScript enabled. Please enable JavaScript to access the full features of the site or access our non-JavaScript page.

Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

Renxian Wang,^a WeiFeng Liu,^b Qian Wang,^a Guangping Li,^a Ben Wan,^a Yuyang Sun,^a Xiaohui Niu,*^b Dafu Chen*^a and Wei Tian^c

Author affiliations

* Corresponding authors

^a Laboratory of Bone Tissue Engineering, Beijing Laboratory of Biomedical Materials, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Beijing 100035, China
E-mail: chendafujst@126.com

^b Depatment of Orthopaedic Oncology Surgery, Beijing JiShuiTan Hospital, Peking Universit, Beijing 100035, China
E-mail: niuxiaohui@263.net

^c Department of Spine Surgery, Beijing JiShuiTan Hospital, Peking University, Beijing 100035, China

Abstract

Correction for ‘Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway’ by Renxian Wang et al., Biomater. Sci., 2020, 8, 4426–4437, DOI: 10.1039/D0BM00898B.

Download options Please wait...

Associated articles

Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vi…

Article information

DOI: https://doi.org/10.1039/D1BM90066H
Article type: Correction
Submitted: 30 Jun 2021
Accepted: 30 Jun 2021
First published: 08 Jul 2021
This article is Open Access

Download Citation

Biomater. Sci., 2021,9, 5383-5384

Permissions

Request permissions

Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

R. Wang, W. Liu, Q. Wang, G. Li, B. Wan, Y. Sun, X. Niu, D. Chen and W. Tian, Biomater. Sci., 2021, 9, 5383 DOI: 10.1039/D1BM90066H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Social activity

Fetching data from CrossRef.
This may take some time to load.

Biomaterials Science

Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway

Social activity

Search articles by author

Spotlight

Advertisements